Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jerome Lewis Avorn, M.D.

Co-Author

This page shows the publications co-authored by Jerome Avorn and Troyen Brennan.
Connection Strength

0.703
  1. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women. Am J Obstet Gynecol. 2016 09; 215(3):353.e1-353.e18.
    View in: PubMed
    Score: 0.043
  2. Comparative effectiveness of generic versus brand-name antiepileptic medications. Epilepsy Behav. 2015 Nov; 52(Pt A):14-8.
    View in: PubMed
    Score: 0.041
  3. Long-term cost-effectiveness of providing full coverage for preventive medications after myocardial infarction. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):252-9.
    View in: PubMed
    Score: 0.040
  4. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Ann Intern Med. 2015 Mar 17; 162(6):407-19.
    View in: PubMed
    Score: 0.040
  5. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study. JAMA Intern Med. 2014 Dec; 174(12):1955-62.
    View in: PubMed
    Score: 0.039
  6. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med. 2014 Sep 16; 161(6):400-7.
    View in: PubMed
    Score: 0.038
  7. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications. Am J Med. 2014 Nov; 127(11):1075-1082.e1.
    View in: PubMed
    Score: 0.038
  8. Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic. Am J Public Health. 2014 Jun; 104(6):1052-8.
    View in: PubMed
    Score: 0.037
  9. Five features of value-based insurance design plans were associated with higher rates of medication adherence. Health Aff (Millwood). 2014 Mar; 33(3):493-501.
    View in: PubMed
    Score: 0.037
  10. Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):724-31.
    View in: PubMed
    Score: 0.036
  11. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J. 2014 Jan; 167(1):51-58.e5.
    View in: PubMed
    Score: 0.036
  12. Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res. 2012 Dec; 47(6):2097-117.
    View in: PubMed
    Score: 0.034
  13. Warnings without guidance: patient responses to an FDA warning about ezetimibe. Med Care. 2012 Jun; 50(6):479-84.
    View in: PubMed
    Score: 0.033
  14. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med. 2012 Mar; 125(3):302.e1-7.
    View in: PubMed
    Score: 0.032
  15. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 01; 365(22):2088-97.
    View in: PubMed
    Score: 0.032
  16. Trouble getting started: predictors of primary medication nonadherence. Am J Med. 2011 Nov; 124(11):1081.e9-22.
    View in: PubMed
    Score: 0.032
  17. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011 May 09; 171(9):814-22.
    View in: PubMed
    Score: 0.031
  18. The consequences of requesting "dispense as written". Am J Med. 2011 Apr; 124(4):309-17.
    View in: PubMed
    Score: 0.030
  19. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med. 2010 Nov 16; 153(10):633-40.
    View in: PubMed
    Score: 0.030
  20. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008 Jul; 156(1):31-6.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.